Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer

Published:2024-09 Issue: Volume:180 Page:108989
ISSN:0010-4825
Container-title:Computers in Biology and Medicine
language:en
Short-container-title:Computers in Biology and Medicine

Author:

Xu Wenbo,Liu Shuai,Ma Longtu,Cheng Long,Li Qingchao,Qing Liangliang,Yang Yongjin,Dong Zhilong^ORCID

Funder

University Project of Gansu Province

Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutesof China

Support Program for Longyuan Youth and Fundamental Research Funds for the Universities of Gansu Province

National Natural Science Foundation of China-Yunnan Joint Fund

Publisher

Elsevier BV

Reference47 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021

2. Cancer statistics, 2023;Siegel;CA A Cancer J. Clin.,2023

3. Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment;Xu;J. Immunother. Cancer,2023

4. Metastatic prostate cancer remains incurable, why?;Dong;Asian J. Urol.,2019

5. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer;Daskivich;Ann. Intern. Med.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP